Free Trial

Vital Farms, Inc. (NASDAQ:VITL) Receives $44.63 Consensus PT from Analysts

Vital Farms logo with Consumer Staples background

Shares of Vital Farms, Inc. (NASDAQ:VITL - Get Free Report) have received a consensus recommendation of "Buy" from the nine analysts that are currently covering the firm, Marketbeat Ratings reports. Eight research analysts have rated the stock with a buy rating and one has issued a strong buy rating on the company. The average 1-year target price among analysts that have issued ratings on the stock in the last year is $44.63.

A number of research firms have recently issued reports on VITL. William Blair restated an "outperform" rating on shares of Vital Farms in a report on Friday, February 28th. BMO Capital Markets raised shares of Vital Farms to a "strong-buy" rating in a research report on Tuesday, May 6th. Stifel Nicolaus raised Vital Farms from a "hold" rating to a "buy" rating and set a $44.00 price target on the stock in a research report on Friday, February 28th. Morgan Stanley lowered their price target on Vital Farms from $40.00 to $39.00 and set an "overweight" rating on the stock in a research report on Thursday, April 17th. Finally, Telsey Advisory Group reaffirmed an "outperform" rating and issued a $52.00 price target on shares of Vital Farms in a research report on Monday, May 5th.

Get Our Latest Stock Report on Vital Farms

Insider Buying and Selling

In other Vital Farms news, CEO Russell Diez-Canseco sold 45,124 shares of Vital Farms stock in a transaction on Monday, April 14th. The shares were sold at an average price of $33.69, for a total transaction of $1,520,227.56. Following the completion of the sale, the chief executive officer now owns 703,736 shares of the company's stock, valued at approximately $23,708,865.84. The trade was a 6.03% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, insider Matthew Ohayer sold 4,000 shares of the company's stock in a transaction dated Monday, March 24th. The shares were sold at an average price of $31.39, for a total value of $125,560.00. Following the completion of the sale, the insider now owns 6,966,890 shares of the company's stock, valued at $218,690,677.10. This represents a 0.06% decrease in their position. The disclosure for this sale can be found here. Insiders sold 93,124 shares of company stock worth $3,019,308 in the last quarter. Insiders own 27.60% of the company's stock.

Hedge Funds Weigh In On Vital Farms

Large investors have recently added to or reduced their stakes in the company. CIBC Private Wealth Group LLC boosted its position in shares of Vital Farms by 152.1% during the fourth quarter. CIBC Private Wealth Group LLC now owns 895 shares of the company's stock worth $35,000 after buying an additional 540 shares during the period. US Bancorp DE boosted its position in shares of Vital Farms by 160.3% during the fourth quarter. US Bancorp DE now owns 1,416 shares of the company's stock worth $53,000 after buying an additional 872 shares during the period. Frazier Financial Advisors LLC bought a new stake in Vital Farms during the 4th quarter worth about $59,000. Mendota Financial Group LLC bought a new stake in Vital Farms during the 4th quarter worth about $62,000. Finally, Principal Securities Inc. lifted its position in Vital Farms by 29.4% during the 4th quarter. Principal Securities Inc. now owns 1,673 shares of the company's stock worth $63,000 after buying an additional 380 shares in the last quarter. Institutional investors own 98.59% of the company's stock.

Vital Farms Stock Performance

Shares of NASDAQ VITL traded up $0.15 during midday trading on Wednesday, hitting $33.97. The company's stock had a trading volume of 95,489 shares, compared to its average volume of 1,028,344. The company has a debt-to-equity ratio of 0.04, a quick ratio of 2.81 and a current ratio of 3.24. The firm's fifty day moving average price is $32.50 and its 200-day moving average price is $35.07. The firm has a market cap of $1.51 billion, a P/E ratio of 30.34 and a beta of 0.94. Vital Farms has a 1-year low of $27.91 and a 1-year high of $48.41.

Vital Farms (NASDAQ:VITL - Get Free Report) last issued its quarterly earnings results on Thursday, May 8th. The company reported $0.37 earnings per share for the quarter, topping analysts' consensus estimates of $0.26 by $0.11. The company had revenue of $162.19 million during the quarter, compared to analyst estimates of $164.43 million. Vital Farms had a net margin of 8.68% and a return on equity of 22.29%. The business's revenue for the quarter was up 9.7% compared to the same quarter last year. During the same period in the prior year, the business posted $0.43 EPS. On average, sell-side analysts forecast that Vital Farms will post 1.11 EPS for the current fiscal year.

About Vital Farms

(Get Free Report

Vital Farms, Inc, a food company, provides pasture-raised products in the United States. It offers shell eggs, butter, hard-boiled eggs, and liquid whole eggs. The company was founded in 2007 and is headquartered in Austin, Texas.

Further Reading

Analyst Recommendations for Vital Farms (NASDAQ:VITL)

Should You Invest $1,000 in Vital Farms Right Now?

Before you consider Vital Farms, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Vital Farms wasn't on the list.

While Vital Farms currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

13 Stocks Institutional Investors Won't Stop Buying Cover

Which stocks are hedge funds and endowments buying in today's market? Enter your email address and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying now.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

This $13 Trillion Energy Breakthrough Will Make Millionaires
Magnificent 7 Stocks Shift Toward Stability and Selective Growth
4 Biotech Stocks on the Verge of Massive Breakthroughs

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines